Diane Redington is the founder, heart, and soul of The GCS Project. We would not be doing this work without her grit, drive, and optimism. Fortunately, The GCS Project team is not the only organization to recognize her singular contributions to date.
The GCS Project founder, Diane Redington, was posthumously recognized as a Distinguished Alumna at Peoria High School on October 6, 2018, for her career accomplishments and generous service to others. Diane’s husband, Roy Buchta and son Matt accepted the award.
Created and supported by the Massachusetts General Hospital Cancer Center, The One Hundred is an awareness and fundraising initiative that celebrates hope in the cancer community. Each year, The One Hundred honors 100 Everyday Amazing individuals and groups — caregivers, researchers, philanthropists, advocates and volunteers from around the globe — whose commitment to the fight against cancer inspires us all to take action.
The first of its kind, the Spotlight Awards shine a light on the achievements of truly remarkable people, products, and services in the cancer community. Nominated by the public, and voted by a panel of expert judges, the winners are from all walks of life, of all ages, and from across the world.
Great Nonprofits is the leading platform for community-sourced stories about nonprofits. These stories are submitted by people who know you best – your clients, donors, volunteers, and others – all those who have experienced the impact of nonprofit work up close!
Thanks to the generosity of countless supporters for the past ten years in honor of founder Diane Redington, The GCS Project is helping change what is possible for women battling… Read More »
Clinical trials are currently being offered at the University of Arkansas for Medical Sciences (UAMS). Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single… Read More »
Clinical trials are currently being offered at the University of Alabama at Birmingham. Immunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in… Read More »